U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 70

Tests names and labsConditionsGenes, analytes, and microbesMethods

Polycythemia vera

Molecular Genetics Laboratory London Health Sciences Centre
Canada
11
  • T Targeted variant analysis

NGS Panel for Congenital Erythrocythosis or Familiar Polycythemia

BloodGenetics
Spain
1211
  • C Sequence analysis of the entire coding region

JAK2 Targeted Mutation Analysis (V617F)

Genetics Center
United States
31
  • T Targeted variant analysis

Cancer Hotspot Panel

Genome-Nilou Lab
Iran
4534
  • E Sequence analysis of select exons

Invitae Inborn Errors of Immunity and Cytopenias Panel

Invitae
United States
754562
  • D Deletion/duplication analysis

Invitae Familial Essential Thrombocythemia Panel

Invitae
United States
93
  • D Deletion/duplication analysis

Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel

PreventionGenetics, part of Exact Sciences
United States
346160
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MarrowZoom

Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital
United States
249155
  • C Sequence analysis of the entire coding region

Inherited Bone Marrow Failure Panel

PreventionGenetics, part of Exact Sciences
United States
266186
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Polycythemia vera, somatic, 263300; PV (Polycythemia vera) V617F Mutation and (Exon 12-14) (JAK2 gene) (Dizi Analizi) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • E Sequence analysis of select exons

Calreticulin Exon 9 Mutation, JAK2 V617F Quant and Exons 12-15 and MPL Mutation Analysis

PathGroup
United States
93
  • T Targeted variant analysis

JAK2 V617F Mutation Detect and Quant and JAK2 Exons12-15 Mutation Analysis

PathGroup
United States
51
  • T Targeted variant analysis

Calreticulin Exon 9 Mutation, MPL Mutation analysis and JAK2 Exons12-15 Mutation Analysis

PathGroup
United States
93
  • T Targeted variant analysis

Calreticulin Exon 9 Mutation and MPL Mutation analysis

PathGroup
United States
82
  • T Targeted variant analysis

Calreticulin Exon 9 Mutation and JAK2 V617F Quant and Exons 12-15

PathGroup
United States
82
  • T Targeted variant analysis

Calreticulin Exon 9 Mutation, MPL and JAK2 V617F Quant

PathGroup
United States
93
  • T Targeted variant analysis

Calreticulin Exon 9 Mutation and JAK2 V617F Quant

PathGroup
United States
82
  • T Targeted variant analysis

HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and T-Cell Clonality Analysis

PathGroup
United States
23160
  • T Targeted variant analysis

HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and JAK2 V617F Quant

PathGroup
United States
18160
  • T Targeted variant analysis

BCR/ABL IS Quant CML and JAK2 V617F Quant and JAK2 Exon 12-15

PathGroup
United States
73
  • T Targeted variant analysis

Results: 1 to 20 of 70

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.